Medtronic's OmniaSecure has now become the first lead of its kind to secure FDA approval. Credit: mi_viri / ShutterStock.com. · Medical Device Network · mi_viri / ShutterStock.com. US-based Protaryx ...

LEXINGTON, S.C., Sept. 9, 2026 /PRNewswire/ -- ElectroWire Medical, developer of the FDA-cleared LightningWire™ Transseptal Puncture System, today announced the successful completion of its first ...

TORONTO, Nov. 5, 2019 /PRNewswire/ - A randomized controlled trial has found that use of Baylis Medical's NRG® Transseptal Needle results in shorter time in achieving transseptal access, less ...

Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA.

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...

The occurrence of acute brain lesions was lower with a transseptal puncture than with a conventional retrograde aortic approach in patients undergoing left ventricular catheter ablation, with no ...

MIAMI, April 1, 2022 /PRNewswire/ -- East End Medical, a private medical device company committed to improving catheter-based cardiac procedures, today announced the first commercial uses of its ...

LEXINGTON, S.C., July 15, 2026 /PRNewswire/ -- ElectroWire Medical announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its LightningWireTM Transseptal Puncture ...

Protaryx Medical, an innovative medical device company developing differentiated access solutions for minimally invasive left-heart procedures, today announced the successful completion of the first U ...